PIANP: A Drug Target / Disease Biomarker (G196500)

Target Name: PIANP

NCBI ID: G196500

PIANP

PIANP: A Drug Target / Disease Biomarker

Pain is a fundamental human experience that is associated with significant morbidity and mortality. Chronic pain, in particular, can significantly impact an individual's quality of life and overall well-being. The painkiller market is one of the largest pharmaceutical markets in the world, with an estimated annual sales of over $300 billion. However, the current painkiller drugs that are available are often limited in their effectiveness and can have significant side effects. As a result, there is a growing need for new and innovative painkillers that can provide more effective and fewer side effects.

One potential drug that is being investigated as a pain target is PIANP (pronounced pi-anna). PIANP is a small protein that is expressed in the endoplasmic reticulum (ER) and has been shown to play a role in pain signaling. PIANP has been shown to interact with multiple pain signaling pathways, including the TRPV1 receptor, which is responsible for mediating pain signals.

In addition to its potential role in pain signaling, PIANP has also been shown to have potential as a drug target. PIANP has been shown to interact with several intracellular signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cellular signaling, including the regulation of pain signaling. By targeting this pathway, PIANP has the potential to modulate pain signaling and provide effective pain relief.

PIANP has also been shown to interact with the GPR117 receptor, which is a potential drug target for chronic pain. The GPR117 receptor is involved in the regulation of pain signaling and has been shown to play a role in the development of chronic pain. PIANP has been shown to interact with GPR117, which could potentially modulate pain signaling and provide effective pain relief.

In conclusion, PIANP is a promising drug target for pain relief. Its interaction with multiple pain signaling pathways, including TRPV1 and GPR117, makes it a promising candidate for pain relief. Further research is needed to fully understand the role of PIANP in pain signaling and its potential as a drug target.

Protein Name: PILR Alpha Associated Neural Protein

Functions: Acts as a ligand for PILRA in neural tissues, where it may be involved in immune regulation

The "PIANP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIANP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets